No connection between IVC and stonesNo Reported Renal Stones with Intravenous Vitamin C Administration: A Prospective Case Series Study.
We set out to investigate whether high doses of intravenous vitamin C (IVC) could influence the formation of kidney stones. Our study involved 157 adult patients receiving IVC therapy at Integrated Health Options clinic over a 12-month period.
Throughout the study, we conducted regular check-ins with patients, specifically asking about any kidney stones they might have experienced, along with monitoring their renal function through blood tests. Despite some patients having a prior history of kidney stones, we found that none reported developing new stones during the study.
Interestingly, we also noted that the majority of participants showed stable renal function, as indicated by consistent serum creatinine levels and estimated glomerular filtration rates (eGFR). In summary, our findings suggest that IVC therapy does not appear to be associated with an increased risk of kidney stones.
Read More
Ester-C shows promise for kidney stonesVitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.
We examined how different vitamin C formulations affect kidney stones, particularly focusing on Ester-C. This well-structured study utilized a randomized, double-blind, crossover design to assess the impact of Ester-C compared to regular ascorbic acid.
We found that Ester-C significantly lowered urine oxalate levels, a key risk factor for kidney stones. This discovery could be a promising step forward, but it also emphasizes the need for further clinical studies to fully understand its effects.
Read More
CDAI may reduce kidney stonesHigh composite dietary antioxidant index is associated with reduced risk of kidney stones: a cross-sectional analysis of NHANES 2007-2020.
We examined the relationship between dietary antioxidant intake, particularly vitamin C, and the risk of developing kidney stones. Utilizing data from the National Health and Nutrition Examination Survey, we found that individuals with higher levels of antioxidants, as indicated by the Composite Dietary Antioxidant Index (CDAI), had lower odds of forming kidney stones.
Stone formers, those who have experienced kidney stones, typically had a lower CDAI, showcasing significant differences based on gender. An interesting aspect of our findings was that vitamin C stood out as having the strongest negative correlation with kidney stones, suggesting that increased intake may be beneficial.
The results indicated that those in moderate and high CDAI groups had reduced odds of experiencing kidney stones compared to the lowest group. This was reflected in the odds ratios, which showed a significant decrease for those with higher antioxidant consumption. Therefore, it seems that a diet rich in antioxidants, particularly vitamin C, could play a role in lowering kidney stone risks.
However, while our findings are promising, we emphasize the need for more in-depth cohort studies to further investigate this potential connection and confirm its causal nature.
Read More
Vitamin C may reduce kidney stonesEvaluating the American Urologic Association (AUA) dietary recommendations for kidney stone management using the National Health And Nutritional Examination Survey (NHANES).
We explored the dietary habits of individuals from the National Health and Nutritional Examination Survey (NHANES) to see how certain foods might influence kidney stone formation.
Our focus was particularly on vitamin C and its potential role in preventing these painful stones. We looked at a diverse group of nearly 17,000 people, analyzing their dietary intake alongside their kidney health over a span of several years.
Interestingly, our findings highlighted a connection between higher vitamin C intake and reduced kidney stone risk. Specifically, we noted that individuals consuming 60 to 110 mg of vitamin C daily had a lower chance of forming stones, with an even greater protective effect observed in those exceeding that amount.
While we didn't find significant associations with many other dietary elements, our results suggest that increasing vitamin C intake might be beneficial. This points towards a need for further research on how vitamin C and other dietary factors interact in the context of kidney stone prevention.
Read More
Vitamin C formulation lowers oxalateVitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.
We examined how different forms of vitamin C affect kidney stones, specifically looking at hyperoxaluria, a key risk factor for stone formation. In our study, conducted as a randomized, double-blind, crossover trial, we compared the effects of traditional ascorbic acid with a formulation containing vitamin C and metabolites, known as Ester-C.
Our findings revealed that Ester-C significantly lowered urine oxalate levels compared to regular ascorbic acid. This is exciting because higher oxalate levels in urine can lead to kidney stones, and finding a formulation that mitigates this risk is important.
Although this study presents promising results, it's essential to note that further evaluation is necessary to fully understand these findings. We believe this is a novel insight into the potential of vitamin C to help prevent kidney stones, and we look forward to additional research in this area.
Read More